PGK2 and gastric cancer: Importantly, GC patients with high PGK2 expression had 2.41-times higher mortality risk than patients with low PGK2 expression (HR: 2.4L, 95% CI 1.0–5.9), indicating that PGK2 was the most effective prognostic marker among all the analyzed ARGs.